[Lavomax in outpatient treatment of urogenital chlamidiasis in males].
Sixty four males (age 21-45 years) with urogenital chlamidiasis were divided into two groups. 34 patients of the study group received interferon inductor and lavomax. 30 patients of the control group--interferon inductor and cycloferon. Treatment efficacy in the study group was higher.
Leont'ev
I G
IG
D000328:Adult; D002690:Chlamydia Infections / Q000188:drug therapy*; D002692:Chlamydia trachomatis; D003131:Combined Modality Therapy; D005832:Genital Diseases, Male / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D015231:Sexually Transmitted Diseases, Bacterial / Q000188:drug therapy*; D013994:Tilorone / Q000627:therapeutic use*; D016896:Treatment Outcome; D014570:Urologic Diseases / Q000188:drug therapy* / Q000382:microbiology
D013994:Tilorone